Drug class in one race
Type I interferon receptor drugs for Multiple Sclerosis
4 tracked Type I interferon receptor drugs in the Multiple Sclerosis race. The class explanation lives on the Type I interferon receptor page; the full indication pipeline across every mechanism is on the Multiple Sclerosis page.
4 approved / phase 4
Head-to-head evidence: Interferon beta-1b vs Interferon-beta1 · Interferon beta-1b vs Rebif (interferon beta 1a) · Interferon beta-1b vs peginterferon beta-1a · Interferon-beta1 vs Rebif (interferon beta 1a) · Interferon-beta1 vs peginterferon beta-1a · peginterferon beta-1a vs Rebif (interferon beta 1a)